Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian centre View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-07

AUTHORS

Alysson Wann, David Ashley, Mustafa Khasraw

ABSTRACT

PURPOSE: Data on the use of targeted therapies at the end of life are scarce. This study reviews the pattern of use of targeted and potentially futile, toxic, or costly therapies at an Australian cancer centre. METHODS: This retrospective single-centre review of data from patients who died within 3 months of having targeted therapy examined demographic characteristics, types of cancers, types of therapy, age, and lines of prior therapy. RESULTS: Over 24 months, two groups were analysed. Firstly, 889 patients died with 107 patients who were prescribed targeted therapy. Secondly, 457 patients were treated with targeted therapies with 52 patients, (11 %) dying within 3 months. To focus on the 52 patients: median age was 69 years, 65 % were men and 35 % were women, 50 % had haematologic cancers and 50 % had solid tumours. Ten therapeutic agents were represented: a higher total number of deaths among those prescribed erlotinib, bevacizumab, and rituximab. There were no deaths within 3 months of treatment with trastuzumab, ipilimumab, or vemurafenib. The targeted therapy was the first-line treatment in 54 %, second in 15 %, and third and beyond in 15 %. The patient's sex and type of cancer had no statistically significant influence on death within 3 months of targeted treatment. CONCLUSIONS: The use of targeted therapy at the end of life in this single-centre descriptive study was lower than documented in other studies. There is a need to prospectively document the factors leading to this prescribing behaviour to guide future protocols. More... »

PAGES

3023-3028

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00520-016-3124-3

DOI

http://dx.doi.org/10.1007/s00520-016-3124-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014682397

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26887377


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Australia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Targeted Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Palliative Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Terminal Care", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Medical Oncology, Andrew Love Cancer Centre, 70 Swanston St., 3220, Geelong, VIC, Australia", 
            "Olivia Newton John Cancer and Wellness Centre, 145 Studley Rd, 3084, Heidelberg, VIC, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wann", 
        "givenName": "Alysson", 
        "id": "sg:person.01135055523.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135055523.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Deakin University", 
          "id": "https://www.grid.ac/institutes/grid.1021.2", 
          "name": [
            "Department of Medical Oncology, Andrew Love Cancer Centre, 70 Swanston St., 3220, Geelong, VIC, Australia", 
            "Department of Medicine, Deakin University, Geelong, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ashley", 
        "givenName": "David", 
        "id": "sg:person.01222136634.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222136634.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Health and Medical Research Council", 
          "id": "https://www.grid.ac/institutes/grid.431143.0", 
          "name": [
            "Department of Medical Oncology, Andrew Love Cancer Centre, 70 Swanston St., 3220, Geelong, VIC, Australia", 
            "Department of Medicine, Deakin University, Geelong, Australia", 
            "NHMRC Clinical Trials Centre, Lifehouse Building, Level 6, 119-143 Missenden Road, 2050, Camperdown, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khasraw", 
        "givenName": "Mustafa", 
        "id": "sg:person.01235517261.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235517261.34"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/imj.12245", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003291884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-1468", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006534187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa065044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007947936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-010-1024-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009973972", 
          "https://doi.org/10.1007/s00520-010-1024-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pon.1140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009978334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature03095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010000533", 
          "https://doi.org/10.1038/nature03095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature03095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010000533", 
          "https://doi.org/10.1038/nature03095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.28614", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010537312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70412-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012736808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq778", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018641716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq778", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018641716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.11-10-1095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019457006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpainsymman.2012.07.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019814071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.53.1186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033123687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.08.136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040533610"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-007-0316-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042019767", 
          "https://doi.org/10.1007/s00520-007-0316-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-007-0316-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042019767", 
          "https://doi.org/10.1007/s00520-007-0316-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa050753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042907915"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa050753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042907915"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043890593", 
          "https://doi.org/10.1038/nrc1360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043890593", 
          "https://doi.org/10.1038/nrc1360"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1112302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051449373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/jpm.2010.0084", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059287341"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ewjm.172.5.310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062812380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.8.2825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083306005"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-07", 
    "datePublishedReg": "2016-07-01", 
    "description": "PURPOSE: Data on the use of targeted therapies at the end of life are scarce. This study reviews the pattern of use of targeted and potentially futile, toxic, or costly therapies at an Australian cancer centre.\nMETHODS: This retrospective single-centre review of data from patients who died within 3\u00a0months of having targeted therapy examined demographic characteristics, types of cancers, types of therapy, age, and lines of prior therapy.\nRESULTS: Over 24\u00a0months, two groups were analysed. Firstly, 889 patients died with 107 patients who were prescribed targeted therapy. Secondly, 457 patients were treated with targeted therapies with 52 patients, (11\u00a0%) dying within 3\u00a0months. To focus on the 52 patients: median age was 69\u00a0years, 65\u00a0% were men and 35\u00a0% were women, 50\u00a0% had haematologic cancers and 50\u00a0% had solid tumours. Ten therapeutic agents were represented: a higher total number of deaths among those prescribed erlotinib, bevacizumab, and rituximab. There were no deaths within 3\u00a0months of treatment with trastuzumab, ipilimumab, or vemurafenib. The targeted therapy was the first-line treatment in 54\u00a0%, second in 15\u00a0%, and third and beyond in 15\u00a0%. The patient's sex and type of cancer had no statistically significant influence on death within 3\u00a0months of targeted treatment.\nCONCLUSIONS: The use of targeted therapy at the end of life in this single-centre descriptive study was lower than documented in other studies. There is a need to prospectively document the factors leading to this prescribing behaviour to guide future protocols.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00520-016-3124-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1103473", 
        "issn": [
          "0941-4355", 
          "1433-7339"
        ], 
        "name": "Supportive Care in Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "24"
      }
    ], 
    "name": "Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian centre", 
    "pagination": "3023-3028", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "45f351b1440f1ed743abea87aaa64508bf68dec06402de57b0f0c64ddc97d920"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26887377"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9302957"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00520-016-3124-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014682397"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00520-016-3124-3", 
      "https://app.dimensions.ai/details/publication/pub.1014682397"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000511.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00520-016-3124-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00520-016-3124-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00520-016-3124-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00520-016-3124-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00520-016-3124-3'


 

This table displays all metadata directly associated to this object as RDF triples.

196 TRIPLES      21 PREDICATES      59 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00520-016-3124-3 schema:about N2964c32f8e9c4f81b905597dfb7502fc
2 N36c8b480da7a4c4eb2d431975d070e54
3 N3b7dff8591114b2384b275f6b03352d2
4 N5ce488b5084342099420bb4ad655ed45
5 N61dc6c82e218452ea186161355bfbb38
6 N65bbd75040b141dfb087c89352efa06b
7 N7bab0acbcd114e67bfade7ab6c33c6e2
8 N9f272bb8a68e4c0c96286bd6cb24f0be
9 Nd1e7ddbf75f345fda9aa028d87a862ac
10 Ne7cd867120504633b698eb8a08d671a7
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author N6df8fa77ad914908bcfbaf91515d327c
14 schema:citation sg:pub.10.1007/s00520-007-0316-x
15 sg:pub.10.1007/s00520-010-1024-5
16 sg:pub.10.1038/nature03095
17 sg:pub.10.1038/nrc1360
18 https://doi.org/10.1002/cncr.28614
19 https://doi.org/10.1002/pon.1140
20 https://doi.org/10.1016/j.jpainsymman.2012.07.007
21 https://doi.org/10.1016/s1470-2045(12)70412-6
22 https://doi.org/10.1056/nejmoa050753
23 https://doi.org/10.1056/nejmoa065044
24 https://doi.org/10.1056/nejmoa1112302
25 https://doi.org/10.1089/jpm.2010.0084
26 https://doi.org/10.1093/annonc/mdq778
27 https://doi.org/10.1111/imj.12245
28 https://doi.org/10.1136/ewjm.172.5.310
29 https://doi.org/10.1158/1078-0432.ccr-11-1468
30 https://doi.org/10.1200/jco.1998.16.8.2825
31 https://doi.org/10.1200/jco.2004.08.136
32 https://doi.org/10.1200/jco.2013.53.1186
33 https://doi.org/10.1634/theoncologist.11-10-1095
34 schema:datePublished 2016-07
35 schema:datePublishedReg 2016-07-01
36 schema:description PURPOSE: Data on the use of targeted therapies at the end of life are scarce. This study reviews the pattern of use of targeted and potentially futile, toxic, or costly therapies at an Australian cancer centre. METHODS: This retrospective single-centre review of data from patients who died within 3 months of having targeted therapy examined demographic characteristics, types of cancers, types of therapy, age, and lines of prior therapy. RESULTS: Over 24 months, two groups were analysed. Firstly, 889 patients died with 107 patients who were prescribed targeted therapy. Secondly, 457 patients were treated with targeted therapies with 52 patients, (11 %) dying within 3 months. To focus on the 52 patients: median age was 69 years, 65 % were men and 35 % were women, 50 % had haematologic cancers and 50 % had solid tumours. Ten therapeutic agents were represented: a higher total number of deaths among those prescribed erlotinib, bevacizumab, and rituximab. There were no deaths within 3 months of treatment with trastuzumab, ipilimumab, or vemurafenib. The targeted therapy was the first-line treatment in 54 %, second in 15 %, and third and beyond in 15 %. The patient's sex and type of cancer had no statistically significant influence on death within 3 months of targeted treatment. CONCLUSIONS: The use of targeted therapy at the end of life in this single-centre descriptive study was lower than documented in other studies. There is a need to prospectively document the factors leading to this prescribing behaviour to guide future protocols.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree false
40 schema:isPartOf Nb4f683b7e910450a9483e15d6b6f9e01
41 Ne27b408189004a9c9f1d25acb04ba76e
42 sg:journal.1103473
43 schema:name Use of targeted therapy in cancer patients in the end-of-life period: results from an Australian centre
44 schema:pagination 3023-3028
45 schema:productId N2f8366953d334862a97ca659916637ef
46 N54763a3b062544d5b05f689370462b63
47 N5b11f56fc16a46ca8a8bb62ceb4b2512
48 N8f57eb9a50bc451997e0c378e0770c5f
49 Nbc57199467564a85b2c3c31b34661cd6
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014682397
51 https://doi.org/10.1007/s00520-016-3124-3
52 schema:sdDatePublished 2019-04-10T19:08
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher N7d71be9119f14047b4bf01a52cb904f7
55 schema:url http://link.springer.com/10.1007%2Fs00520-016-3124-3
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N2964c32f8e9c4f81b905597dfb7502fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Aged
61 rdf:type schema:DefinedTerm
62 N2f8366953d334862a97ca659916637ef schema:name dimensions_id
63 schema:value pub.1014682397
64 rdf:type schema:PropertyValue
65 N36c8b480da7a4c4eb2d431975d070e54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Neoplasms
67 rdf:type schema:DefinedTerm
68 N3b7dff8591114b2384b275f6b03352d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Retrospective Studies
70 rdf:type schema:DefinedTerm
71 N54763a3b062544d5b05f689370462b63 schema:name readcube_id
72 schema:value 45f351b1440f1ed743abea87aaa64508bf68dec06402de57b0f0c64ddc97d920
73 rdf:type schema:PropertyValue
74 N5b11f56fc16a46ca8a8bb62ceb4b2512 schema:name nlm_unique_id
75 schema:value 9302957
76 rdf:type schema:PropertyValue
77 N5ce488b5084342099420bb4ad655ed45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Humans
79 rdf:type schema:DefinedTerm
80 N61dc6c82e218452ea186161355bfbb38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Molecular Targeted Therapy
82 rdf:type schema:DefinedTerm
83 N65bbd75040b141dfb087c89352efa06b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Female
85 rdf:type schema:DefinedTerm
86 N6d47179f327d419f9c53c0f763865306 schema:name Department of Medical Oncology, Andrew Love Cancer Centre, 70 Swanston St., 3220, Geelong, VIC, Australia
87 Olivia Newton John Cancer and Wellness Centre, 145 Studley Rd, 3084, Heidelberg, VIC, Australia
88 rdf:type schema:Organization
89 N6df8fa77ad914908bcfbaf91515d327c rdf:first sg:person.01135055523.69
90 rdf:rest N7fdaf3df22f34e54ab1a65bef0af2208
91 N7bab0acbcd114e67bfade7ab6c33c6e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Australia
93 rdf:type schema:DefinedTerm
94 N7d71be9119f14047b4bf01a52cb904f7 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N7fdaf3df22f34e54ab1a65bef0af2208 rdf:first sg:person.01222136634.47
97 rdf:rest Ndf2443e6279a4a3f9005e0ee9d57f7f2
98 N8f57eb9a50bc451997e0c378e0770c5f schema:name doi
99 schema:value 10.1007/s00520-016-3124-3
100 rdf:type schema:PropertyValue
101 N9f272bb8a68e4c0c96286bd6cb24f0be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Terminal Care
103 rdf:type schema:DefinedTerm
104 Nb4f683b7e910450a9483e15d6b6f9e01 schema:issueNumber 7
105 rdf:type schema:PublicationIssue
106 Nbc57199467564a85b2c3c31b34661cd6 schema:name pubmed_id
107 schema:value 26887377
108 rdf:type schema:PropertyValue
109 Nd1e7ddbf75f345fda9aa028d87a862ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Male
111 rdf:type schema:DefinedTerm
112 Ndf2443e6279a4a3f9005e0ee9d57f7f2 rdf:first sg:person.01235517261.34
113 rdf:rest rdf:nil
114 Ne27b408189004a9c9f1d25acb04ba76e schema:volumeNumber 24
115 rdf:type schema:PublicationVolume
116 Ne7cd867120504633b698eb8a08d671a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Palliative Care
118 rdf:type schema:DefinedTerm
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
123 schema:name Oncology and Carcinogenesis
124 rdf:type schema:DefinedTerm
125 sg:journal.1103473 schema:issn 0941-4355
126 1433-7339
127 schema:name Supportive Care in Cancer
128 rdf:type schema:Periodical
129 sg:person.01135055523.69 schema:affiliation N6d47179f327d419f9c53c0f763865306
130 schema:familyName Wann
131 schema:givenName Alysson
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135055523.69
133 rdf:type schema:Person
134 sg:person.01222136634.47 schema:affiliation https://www.grid.ac/institutes/grid.1021.2
135 schema:familyName Ashley
136 schema:givenName David
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222136634.47
138 rdf:type schema:Person
139 sg:person.01235517261.34 schema:affiliation https://www.grid.ac/institutes/grid.431143.0
140 schema:familyName Khasraw
141 schema:givenName Mustafa
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235517261.34
143 rdf:type schema:Person
144 sg:pub.10.1007/s00520-007-0316-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042019767
145 https://doi.org/10.1007/s00520-007-0316-x
146 rdf:type schema:CreativeWork
147 sg:pub.10.1007/s00520-010-1024-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009973972
148 https://doi.org/10.1007/s00520-010-1024-5
149 rdf:type schema:CreativeWork
150 sg:pub.10.1038/nature03095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010000533
151 https://doi.org/10.1038/nature03095
152 rdf:type schema:CreativeWork
153 sg:pub.10.1038/nrc1360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043890593
154 https://doi.org/10.1038/nrc1360
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1002/cncr.28614 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010537312
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1002/pon.1140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009978334
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/j.jpainsymman.2012.07.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019814071
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/s1470-2045(12)70412-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012736808
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1056/nejmoa050753 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042907915
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1056/nejmoa065044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007947936
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1056/nejmoa1112302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051449373
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1089/jpm.2010.0084 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059287341
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1093/annonc/mdq778 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018641716
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1111/imj.12245 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003291884
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1136/ewjm.172.5.310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062812380
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1158/1078-0432.ccr-11-1468 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006534187
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1200/jco.1998.16.8.2825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083306005
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1200/jco.2004.08.136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040533610
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1200/jco.2013.53.1186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033123687
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1634/theoncologist.11-10-1095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019457006
187 rdf:type schema:CreativeWork
188 https://www.grid.ac/institutes/grid.1021.2 schema:alternateName Deakin University
189 schema:name Department of Medical Oncology, Andrew Love Cancer Centre, 70 Swanston St., 3220, Geelong, VIC, Australia
190 Department of Medicine, Deakin University, Geelong, Australia
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.431143.0 schema:alternateName National Health and Medical Research Council
193 schema:name Department of Medical Oncology, Andrew Love Cancer Centre, 70 Swanston St., 3220, Geelong, VIC, Australia
194 Department of Medicine, Deakin University, Geelong, Australia
195 NHMRC Clinical Trials Centre, Lifehouse Building, Level 6, 119-143 Missenden Road, 2050, Camperdown, NSW, Australia
196 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...